oxycodone has been researched along with Arthritis, Degenerative in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.17) | 18.2507 |
| 2000's | 14 (58.33) | 29.6817 |
| 2010's | 6 (25.00) | 24.3611 |
| 2020's | 3 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Bouvy, ML; Dahan, A; Gademan, MGJ; Nelissen, RGHH; Rosendaal, FR; van Brug, HE; van Dorp, ELA | 1 |
| Alhaj-Suliman, SO; Milavetz, G; Salem, AK | 1 |
| Finco, G; Karra, R; Liedgens, H; Margarit, C; Morlion, BJ; Sohns, M; Wild, I | 1 |
| Awan, HM; Deutch, Z; Niedermeier, SR | 1 |
| Arends, RHGP; Bay-Jensen, AC; Karsdal, MA; Keller, DS; Verburg, KM; West, CR | 1 |
| Hammond, G; Kavanagh, S; Kwong, WJ; Okamoto, A; Upmalis, D; Yang, M | 1 |
| Anastasiadis, A; Krämer, J; Teske, W; Theodoridis, T | 1 |
| Bertini, L; Carucci, A; Gatti, A; Mammucari, M; Occhioni, R; Sabato, AF | 1 |
| Friedmann, N; Klutzaritz, V; Webster, L | 1 |
| Hammond, GC; Kavanagh, S; Kwong, WJ; Nelson, W; Upmalis, D; Yang, M | 1 |
| Bansal, M; Happich, M; Klein, R; Wielage, R; Wilson, K | 1 |
| Curran, MP; Lyseng-Williamson, KA | 1 |
| Burns, LH; Butera, PG; Chindalore, VL; Craven, RA; Friedmann, N; Yu, KP | 1 |
| Darke, AC; de Beer, Jde V; Donnelly, GA; Harsanyi, Z; Miceli, PC; Payne, LW; Reiz, JL; Winemaker, MJ | 1 |
| Stiehl, M | 1 |
| Bresnahan, JF; Fritz, KD; Horlocker, TT; Kinney, MO; Lewallen, DG; Locketz, AJ; Prasad, A; Rivera, JM | 1 |
| McHaourab, AS; Veneziano, G | 1 |
| Richards, P | 1 |
| Anić, B; Bilusić, M; Grazio, S | 1 |
| Bozkaya, D; Caro, JJ; Dubois, D; Fleischmann, J; Sabatowski, R; Ward, A | 1 |
| Hale, M; Khanna, S; Thipphawong, J; Tudor, IC | 1 |
| Boyd, RE; Caldwell, JR; Hague, JM; Hale, ME; Iwan, T; Lacouture, PG; Shi, M | 1 |
| Bockow, B; Burch, FX; Dietz, F; Fleischmann, RM; Lacouture, PG; Rapoport, RJ; Roth, SH; Rutstein, J | 1 |
| Spake, A | 1 |
4 review(s) available for oxycodone and Arthritis, Degenerative
| Article | Year |
|---|---|
Model-based Meta-analysis to Compare Primary Efficacy-endpoint, Efficacy-time Course, Safety, and Tolerability of Opioids Used in the Management of Osteoarthritic Pain in Humans.
Topics: Analgesics, Opioid; Humans; Models, Biological; Osteoarthritis; Oxycodone; Oxymorphone; Pain; Randomized Controlled Trials as Topic; Tramadol; Treatment Outcome | 2020 |
Cost-effectiveness of duloxetine in chronic low back pain: a Quebec societal perspective.
Topics: Age Factors; Aged; Amitriptyline; Analgesics; Cardiovascular Diseases; Celecoxib; Chronic Disease; Clinical Trials as Topic; Cost-Benefit Analysis; Duloxetine Hydrochloride; gamma-Aminobutyric Acid; Gastrointestinal Diseases; Humans; Hydromorphone; Low Back Pain; Markov Chains; Middle Aged; Models, Economic; Naproxen; Ontario; Osteoarthritis; Outcome Assessment, Health Care; Oxycodone; Pregabalin; Pyrazoles; Quality-Adjusted Life Years; Quebec; Sulfonamides; Thiophenes | 2013 |
[Controlled release oxycodone--a new option in the treatment of severe and very severe pain. Review of studies on neuropathic, physical activity-related and postoperative pain].
Topics: Administration, Oral; Analgesics, Opioid; Arthritis, Rheumatoid; Back Pain; Delayed-Action Preparations; Diabetic Neuropathies; Humans; Neuralgia; Osteoarthritis; Oxycodone; Pain Measurement; Pain, Postoperative; Quality of Life; Randomized Controlled Trials as Topic | 2004 |
[Oxycodone: a strong opioid in the treatment of patients with arthritis].
Topics: Analgesics, Opioid; Arthritis, Rheumatoid; Humans; Osteoarthritis; Oxycodone; Rheumatic Diseases | 2006 |
12 trial(s) available for oxycodone and Arthritis, Degenerative
| Article | Year |
|---|---|
Serological biomarker profiles of rapidly progressive osteoarthritis in tanezumab-treated patients.
Topics: Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Biomarkers; Case-Control Studies; Female; Humans; Male; Middle Aged; Osteoarthritis; Oxycodone | 2019 |
Bowel function after tapentadol and oxycodone immediate release (IR) treatment in patients with low back or osteoarthritis pain.
Topics: Adolescent; Adult; Analgesics, Opioid; Constipation; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Gastroenteritis; Humans; Laxatives; Low Back Pain; Male; Osteoarthritis; Oxycodone; Pain; Phenols; Surveys and Questionnaires; Tapentadol; Time Factors; Young Adult | 2013 |
[Effective pain relief facilitates exercise therapy : Results of a multicenter study with controlled-release oxycodone in patients with movement pain].
Topics: Analgesics, Opioid; Decompression, Surgical; Delayed-Action Preparations; Diskectomy; Dose-Response Relationship, Drug; Follow-Up Studies; Fractures, Spontaneous; Humans; Osteoarthritis; Osteoarthritis, Spine; Osteoporosis; Oxycodone; Pain; Pain Measurement; Pain, Postoperative; Physical Therapy Modalities; Spinal Fractures; Spinal Fusion; Spinal Stenosis | 2008 |
Adequacy assessment of oxycodone/paracetamol (acetaminophen) in multimodal chronic pain : a prospective observational study.
Topics: Acetaminophen; Adult; Aged; Aged, 80 and over; Amines; Analgesics, Non-Narcotic; Analgesics, Opioid; Chronic Disease; Cyclohexanecarboxylic Acids; Drug Combinations; Drug Therapy, Combination; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Low Back Pain; Male; Middle Aged; Osteoarthritis; Oxycodone; Pain; Pain Measurement; Peripheral Nervous System Diseases; Prospective Studies | 2009 |
Long-term safety of Remoxy® (extended-release oxycodone) in patients with moderate to severe chronic osteoarthritis or low back pain.
Topics: Adolescent; Adult; Aged; Analgesics, Opioid; Arthralgia; Chronic Disease; Delayed-Action Preparations; Female; Humans; Low Back Pain; Male; Middle Aged; Osteoarthritis; Oxycodone; Pain Measurement; Treatment Outcome; Young Adult | 2011 |
Pain relief and tolerability balance of immediate release tapentadol or oxycodone treatment for patients with moderate to severe osteoarthritis or low back pain.
Topics: Adult; Aged; Aged, 80 and over; Analgesics; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Low Back Pain; Male; Middle Aged; Osteoarthritis; Oxycodone; Phenols; Tapentadol; Young Adult | 2012 |
Lumiracoxib.
Topics: Administration, Oral; Arthritis, Rheumatoid; Celecoxib; Cyclooxygenase Inhibitors; Diclofenac; Double-Blind Method; Drug Administration Schedule; Drug Evaluation, Preclinical; Female; Half-Life; Humans; Male; Molecular Structure; New Zealand; Organic Chemicals; Osteoarthritis; Oxycodone; Pain; Pyrazoles; Sulfonamides; Terminology as Topic; World Health Organization | 2004 |
Adding ultralow-dose naltrexone to oxycodone enhances and prolongs analgesia: a randomized, controlled trial of Oxytrex.
Topics: Adolescent; Adult; Aged; Analgesia; Analgesics, Opioid; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Osteoarthritis; Oxycodone; Pain; Pain Measurement; Patient Satisfaction; Treatment Outcome | 2005 |
Efficacy and safety of controlled-release oxycodone and standard therapies for postoperative pain after knee or hip replacement.
Topics: Aged; Analgesics; Analgesics, Opioid; Arthroplasty, Replacement; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Osteoarthritis; Oxycodone; Pain Measurement; Pain, Postoperative; Treatment Outcome | 2005 |
Efficacy and tolerability of once-daily OROS hydromorphone and twice-daily extended-release oxycodone in patients with chronic, moderate to severe osteoarthritis pain: results of a 6-week, randomized, open-label, noninferiority analysis.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Chronic Disease; Delayed-Action Preparations; Female; Hip; Humans; Hydromorphone; Knee; Male; Middle Aged; Osteoarthritis; Oxycodone; Pain | 2007 |
Treatment of osteoarthritis pain with controlled release oxycodone or fixed combination oxycodone plus acetaminophen added to nonsteroidal antiinflammatory drugs: a double blind, randomized, multicenter, placebo controlled trial.
Topics: Acetaminophen; Adult; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Arthrography; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Joints; Male; Middle Aged; Osteoarthritis; Oxycodone; Pain; Pain Measurement; Quality of Life; Sleep; Treatment Outcome | 1999 |
Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain: placebo-controlled trial and long-term evaluation.
Topics: Aged; Analgesics, Opioid; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Middle Aged; Osteoarthritis; Oxycodone; Pain; Severity of Illness Index; Treatment Outcome | 2000 |
8 other study(ies) available for oxycodone and Arthritis, Degenerative
| Article | Year |
|---|---|
What Changes Have Occurred in Opioid Prescriptions and the Prescribers of Opioids Before TKA and THA? A Large National Registry Study.
Topics: Aged; Analgesics, Opioid; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Female; Humans; Male; Opioid-Related Disorders; Osteoarthritis; Oxycodone; Pain, Postoperative; Practice Patterns, Physicians'; Prescriptions; Registries; Retrospective Studies | 2023 |
Bone fractures in patients using tapentadol or oxycodone: an exploratory US claims database study.
Topics: Administrative Claims, Healthcare; Adult; Aged; Analgesics, Opioid; Back Pain; Databases, Factual; Female; Fractures, Bone; Humans; Male; Medicare; Middle Aged; Osteoarthritis; Oxycodone; Pain, Postoperative; Pilot Projects; Retrospective Studies; Tapentadol; United States | 2021 |
Surgeon Preference, Influence, and Treatment of Thumb Carpometacarpal Arthritis.
Topics: Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Carpometacarpal Joints; Clinical Competence; Drug Prescriptions; Humans; Hydrocodone; Immobilization; Orthopedic Procedures; Osteoarthritis; Oxycodone; Pain, Postoperative; Postoperative Care; Practice Patterns, Physicians'; Surgeons; Surveys and Questionnaires; Thumb; United States | 2018 |
"Broken heart syndrome" after separation (from OxyContin).
Topics: Analgesics, Opioid; Arthroplasty, Replacement, Knee; Cardiomyopathies; Female; Humans; Middle Aged; Osteoarthritis; Oxycodone; Perioperative Care; Substance Withdrawal Syndrome; Syndrome; Ventricular Dysfunction, Left | 2006 |
Opioid tolerance remains unaddressed.
Topics: Aged; Aged, 80 and over; Analgesics, Opioid; Cohort Studies; Demography; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Tolerance; Female; Humans; Male; Middle Aged; Osteoarthritis; Oxycodone; Pain; Pain Measurement; Patient Acceptance of Health Care; Patient Satisfaction; Retrospective Studies; Time Factors; Treatment Outcome | 2006 |
Author's response"Opioid tolerance often ignored".
Topics: Aged; Aged, 80 and over; Analgesics, Opioid; Cohort Studies; Demography; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Tolerance; Female; Humans; Male; Middle Aged; Narcotics; Osteoarthritis; Oxycodone; Pain; Pain Measurement; Patient Acceptance of Health Care; Patient Satisfaction | 2006 |
Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: comparison of extended-release oxycodone and OROS hydromorphone.
Topics: Analgesics, Opioid; Chronic Disease; Cohort Studies; Cost-Benefit Analysis; Delayed-Action Preparations; Germany; Humans; Hydromorphone; Osteoarthritis; Oxycodone; Pain; Sleep; Treatment Outcome | 2007 |
'Not an appropriate use'. Did the makers of OxyContin push too hard?
Topics: Analgesics, Opioid; Drug Industry; Drug Prescriptions; Humans; Osteoarthritis; Oxycodone; Pain; Substance-Related Disorders; West Virginia | 2001 |